Marianne Frydenlund

During her career, Marianne has gained a unique in-house perspective on IP-related business practices within the wireless ecosystem. At Avanci, she is developing and leading new licensing programs for the Internet of Things (IoT) beyond the automotive industry. Marianne joined Avanci from Nordic Semiconductor, where she was most recently Senior Vice President, Legal & Compliance, with responsibilities including patent licensing activities, concluding several ground-breaking agreements. Earlier in her career, Marianne worked for Huawei Technologies, Nexans Norway AS, Equinor and Aker Solutions where she focused on legal issues associated with technology-related commercial transactions. Marianne graduated from the University of Oslo School of Law. She chairs the Board of the Norwegian Company Lawyers Association (NCLA) where she has been involved in their mentoring programs aimed at helping women advance in business and technology-related careers.

Andrei Iancu – Congressional Testimony: Hearing on the Patent Eligibility Restoration Act (PERA)

On October 8th, 2025, Andrei Iancu testified before the Senate Judiciary Committee, Subcommittee on Intellectual Property during the Hearing on the Patent Eligibility Restoration Act (PERA). Iancu, Partner at Sullivan & Cromwell, former Under Secretary of Commerce for IP and Director of the U.S. Patent and Trademark Office (USPTO), and
Read More

How Europe Lost Global Biopharmaceutical R&D Leadership to the United States: Lessons for Today

By Anne Prichett Today, the United States leads the world in biopharmaceutical industry research and development (R&D), supporting nearly five million jobs and generating more than $1.65 trillion in economic output. This position of global leadership, however, is relatively recent. Until the late 1980s, Europe–particularly Germany, France,
Read More

If Private Sector R&D Is the Future, IP Policy Must Catch Up

By Chris Borges The President’s Budget Request for fiscal year 2026 (FY 2026) includes steep cuts to federal research and development (R&D) funding—a troubling signal for U.S. innovation and economic security. While congressional committees may push back on the most severe reductions, the signs are clear: Federal R&D funding is likely
Read More